Coherus Oncology, Inc. (CHRS) Revenue History
Coherus Oncology, Inc. (CHRS) annual revenue history. Get revenue data in Excel with MarketXLS.
Revenue Data
| Period | Revenue (USD) |
|---|---|
| 2016-12-31 | $190.11M |
| 2017-12-31 | $1.56M |
| 2018-12-31 | N/A |
| 2019-12-31 | $356.10M |
| 2020-12-31 | $475.82M |
| 2021-12-31 | $326.55M |
| 2022-12-31 | $211.04M |
| 2023-12-31 | $257.24M |
| 2024-12-31 | $26.39M |
| 2025-12-31 | $42.17M |
How CHRS compares with sector peers
| Symbol | Company | Revenue (latest fiscal year) |
|---|---|---|
| OCUL | Ocular Therapeutix Inc. | $51.95M |
| LXRX | Lexicon Pharmaceuticals Inc. | $49.80M |
| GOSS | Gossamer Bio Inc. | $48.47M |
| AQST | Aquestive Therapeutics Inc. | $44.55M |
| VYGR | Voyager Therapeutics Inc. | $40.37M |
These are five companies in the same sector as CHRS with a comparable annual revenue. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Coherus Oncology, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue("CHRS", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | CHRS | $1.45 | +5.84% | 0.90M |
| 3 | ||||
| 4 | ||||
| 5 |